dhis2-users team mailing list archive

[Pamod Amarakoon <pamodm@xxxxxxxxx>]

Great news Lars! we have been eagerly waiting for some improvement on this
access control. Thanx !

On Fri, Dec 8, 2017 at 9:42 PM, Lars Helge Øverland <lars@xxxxxxxxx> wrote:

> Hi Julie,
>
> it's a good question and unfortunately you cannot have this level of
> access control per today. However the good news is that we plan to support
> this in version 2.29 (Feb 1) by introducing a new level of sharing
> <https://docs.dhis2.org/master/en/user/html/sharing.html> access called
> "Data input". Stay tuned.
>
> regards,
>
> Lars
>
>
> On 8 December 2017 at 11:01, Julie Vanhamme <juvhamme@xxxxxxxxx> wrote:
>
>> Hi All,
>>
>> I configured a program (Event) with three different stage. I have
>> different types of users and some of them can only access one stage and not
>> the other ones.
>>
>> How can I limit the access to some of my stages to some users/user roles?
>>
>> Many thanks
>>
>> Julie
>>
>> _______________________________________________
>> Mailing list: https://launchpad.net/~dhis2-users
>> Post to     : dhis2-users@xxxxxxxxxxxxxxxxxxx
>> Unsubscribe : https://launchpad.net/~dhis2-users
>> More help   : https://help.launchpad.net/ListHelp
>>
>>
>
>
> --
> Lars Helge Øverland
> Lead developer, DHIS 2
> University of Oslo
> Skype: larshelgeoverland
> lars@xxxxxxxxx
> http://www.dhis2.org <https://www.dhis2.org/>
>
>
> _______________________________________________
> Mailing list: https://launchpad.net/~dhis2-users
> Post to     : dhis2-users@xxxxxxxxxxxxxxxxxxx
> Unsubscribe : https://launchpad.net/~dhis2-users
> More help   : https://help.launchpad.net/ListHelp
>
>


-- 
Regards,
Dr. Pamod Amarakoon
MBBS (SL)
MSc (Biomedical Informatics), EMSc (Health Admin), PGCert (MedEd), CEH
Medical Officer in Health Informatics
Nutrition Coordination Division
Ministry of Health, Nutrition and Indigenous Medicine,
Sri Lanka

Confidentiality Notice: the information contained in this email and any
attachments may be legally privileged and confidential. If you are not an
intended recipient, you are hereby notified that any dissemination,
distribution, or copying of this e-mail is strictly prohibited. If you have
received this e-mail in error, please notify the sender and permanently
delete the e-mail and any attachments immediately. You should not retain,
copy or use this e-mail or any attachments for any purpose, nor disclose
all or any part of the contents to any other person.